A Phase I, Randomized, Placebo-Controlled, Dose Escalating Cross Over Study To Evaluate The Safety, Toleration, Pharmacokinetics And Pharmacodynamics Of PF-05105679 Under Fasted Conditions In Healthy Volunteers.

Trial Profile

A Phase I, Randomized, Placebo-Controlled, Dose Escalating Cross Over Study To Evaluate The Safety, Toleration, Pharmacokinetics And Pharmacodynamics Of PF-05105679 Under Fasted Conditions In Healthy Volunteers.

Completed
Phase of Trial: Phase I

Latest Information Update: 30 Sep 2011

At a glance

  • Drugs Oxycodone; PF 5105679
  • Indications Pain
  • Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics
  • Acronyms SINGLE DOSE
  • Most Recent Events

    • 30 Sep 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 15 Jul 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top